Percassist
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2374 Walsh Ave, Santa Clara, California,...Phone Number
(650) 996-5875Website
www.percassist-corp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Percassist
PercAssist, Inc. is focused on developing the PercAssist eVAD System, a next-generation extravascular ventricular assist device designed for mechanical circulatory support. Their innovative technology aims to provide direct cardiac compression without the need for vascular access or adjunctive anti-coagulants, addressing significant risks associated with current intravascular devices. The intended clients include patients suffering from cardiogenic shock, advanced heart failure, and long-term heart failure, with a market potential of millions in the United States alone. The company is currently advancing through preclinical and clinical programs to assess the safety and efficacy of their device.Explore more
Percassist Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Percassist your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Percassist has new funding data
Congratulate Masked Content for being promoted to Masked Content at Percassist
Percassist, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Percassist has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Percassist recently announced quarterly report
Product Launch: Get notified when Percassist launches new products
Check out if Percassist is spiking on competitors!
Click to see if Percassist had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Percassist as Masked Content
Find 3 more new buyers
Compare Similar Companies to Percassist
Compare insights from companies similar to Percassist, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Percassist is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Percassist is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Percassist.
Percassist Tech Stack
A closer look at the technologies used by Percassist
Percassist News & Media
PercAssist Announces First Patient Treated in EUREKA Study of PSCA System for Hemodynamic Support in Chronic Heart Failure
SANTA CLARA, Calif.--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology for a minimally invasive, extravascular platform to provide hemodynamic support for chronic heart failure patients, today announced the successful completion of its first patient in the EUREKA First-in-Human clinical study. The case was completed at the Na Homolce Hospital, Prague, Czech Republic, under the direction of principal investigator Professor Petr Neuzil, M.D., Ph.D., FESC
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Percassist
Sign Up For FreeTo access detailed company insights
PercAssist, Inc. is focused on developing the PercAssist eVAD System, a next-generation extravascular ventricular assist device designed for mechanical circulatory support. Their innovative technology aims to provide direct cardiac compression without the need for vascular access or adjunctive anti-coagulants, addressing significant risks associate... Read More
